Nursing Elites

1. What is a common treatment for a child with moderate to severe eczema?

• A. Topical corticosteroids
• B. Oral antibiotics
• C. Frequent saline irrigation
• D. High-calcium diet

Correct answer: A

Rationale: Topical corticosteroids are the correct answer for a child with moderate to severe eczema. These medications are commonly used to reduce inflammation and itching associated with eczema. Oral antibiotics (Choice B) are not typically used in eczema treatment unless there is a secondary bacterial infection. Frequent saline irrigation (Choice C) may aid in wound care but is not a primary treatment for eczema. A high-calcium diet (Choice D) is not a standard treatment for eczema and does not target the underlying inflammatory process that causes eczema symptoms.

2. What is a key dietary consideration for a child with phenylketonuria (PKU)?

• A. High-fiber diet
• B. Low-phenylalanine diet
• C. Increased dairy intake
• D. High-sodium diet

Correct answer: B

Rationale: A low-phenylalanine diet is crucial for managing PKU to prevent neurological damage and maintain normal development. Phenylalanine is an amino acid found in protein-containing foods, and individuals with PKU have difficulty metabolizing it. Consuming foods low in phenylalanine helps prevent the buildup of toxic byproducts in the body. Choices A, C, and D are incorrect. A high-fiber diet, increased dairy intake, and high-sodium diet are not specific dietary considerations for PKU management. In fact, dairy products are a source of protein and phenylalanine, which should be limited in PKU.

3. How does a double-blind experiment work?

• A. Both subject groups take turns receiving each treatment.
• B. Neither subjects nor researchers know which subjects are in the control or experimental group.
• C. Neither group of subjects knows whether they are in the control or experimental group, but the researchers do not know.
• D. Both subject groups know whether they are in the control or experimental group, but the researchers do not know.

Correct answer: B

Rationale: The correct answer is B. In a double-blind experiment, neither the subjects nor the researchers know which subjects are in the control or experimental group. This helps to eliminate bias and ensure that the results are more objective. Choice A is incorrect as in a double-blind experiment, subjects do not take turns receiving each treatment; it is about masking the treatment allocation. Choice C is incorrect because it implies that the researchers are aware of the group allocation, which goes against the principle of blinding in a double-blind study. Choice D is incorrect as both subject groups should not know whether they are in the control or experimental group to maintain the blindness of the study.

4. What is a common symptom of Kawasaki disease?

• A. Persistent fever for more than 5 days
• B. Excessive vomiting
• C. Sudden weight gain
• D. Decreased appetite

Correct answer: A

Rationale: The correct answer is A. Persistent fever lasting more than 5 days is a hallmark symptom of Kawasaki disease, often accompanied by rash and conjunctivitis. Excessive vomiting (choice B), sudden weight gain (choice C), and decreased appetite (choice D) are not typically associated with Kawasaki disease. Therefore, choices B, C, and D can be eliminated as they do not align with the common symptoms of Kawasaki disease.

5. What should be monitored in a child receiving chemotherapy?

• A. Blood glucose levels
• B. Blood cell counts
• C. Weight gain
• D. Skin elasticity

Correct answer: B

Rationale: The correct answer is monitoring blood cell counts. During chemotherapy, it is crucial to monitor blood cell counts to detect potential side effects such as neutropenia (low white blood cell count) and anemia (low red blood cell count). These conditions can increase the risk of infections and fatigue. Monitoring blood glucose levels (Choice A) is not typically a primary concern in children receiving chemotherapy unless they have pre-existing conditions like diabetes. Weight gain (Choice C) and skin elasticity (Choice D) are not directly related to monitoring the effects of chemotherapy in children. Therefore, the most important parameter to monitor in a child receiving chemotherapy is blood cell counts.

Similar Questions